(Bloomberg) — Moderna Inc. and BioNTech SE, the world’s leading Covid-19 vaccine makers, tumbled for the second day in a row, losing roughly $60 billion in combined market value as investors balked at the companies’ lofty valuations. The declines deepened Wednesday with Moderna closing 16% lower and BioNTech dropping 14% as trading volume picked up. The stocks had soared more than 360% each this year through Monday, when both set record closing highs. Wall Street has been divided on the… Source link
Read More »Moderna, BioNTech Plunge As EU Studies Possible Side-effects Of mRNA Shots
By Dhirendra Tripathi Investing.com – Moderna (NASDAQ:MRNA) and BioNTech stocks (NASDAQ:BNTX) slumped by 15% each Wednesday on a report that Europe’s drug regulator is studying three new conditions reported by a small number of people after vaccination with Covid-19 shots to assess if they may be possible side-effects. The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer. Pfizer stock fell 3%. Expenses and profit from the Covid… Source link
Read More »Moderna Joins Top S&P 500 Firms After Value Nearly Triples
(Bloomberg) — Moderna Inc. joins the S&P 500 on Wednesday as the index’s the best performing stock this year — by a mile. The move caps the drugmaker’s transformation from an early-stage biotech to a vaccine maker supplying Covid shots to the world. With a gain of more than 180% so far in 2021, Moderna’s share performance tops the index’s existing leader, L Brands Inc., which has risen about 100%. In the runup to its inclusion in the U.S. benchmark, Moderna’s stock has made fresh… Source link
Read More »Moderna stock ‘has taken on a life of its own’ ahead of S&P 500 entrance
Moderna (MRNA) is set to join the S&P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc. (ALXN). The stock has soared amid the pandemic after its vaccine became instrumental in the fight against coronavirus. Moderna stock has “taken on a life of its own,” Michael Yee, Managing Director and Senior Research Analyst at Jefferies, told Yahoo Finance (video above). “It’s priced in a huge amount of assumptions over the next ten years that haven’t played out yet. People believe… Source link
Read More »Moderna is the Tesla of biotechs, stock price could hit $325: analyst
Moderna, which has seen its stock surge 250% over the past year as it helps vaccinate the world from the coronavirus, will officially enter the S&P 500 on July 21. The news sent shares popping more than 8% to $282 in Friday’s session as the stock will likely be purchased by fund managers who benchmark to the S&P 500. But Jefferies analyst Michael Yee tells Yahoo Finance Live he thinks the run in Moderna stock (MRNA) is far from done. “Moderna is the Tesla of biotech,” says Yee, pointing to… Source link
Read More »Moderna Set to Join S&P 500
NEW YORK, July 15, 2021 /PRNewswire/ — Moderna Inc. (NASD:MRNA) will replace Alexion Pharmaceuticals Inc. (NASD:ALXN) in the S&P 500 effective prior to the opening of trading on Wednesday, July 21. AstraZeneca Plc (LSE:AZN; NASD:AZN) is acquiring Alexion Pharmaceuticals in a deal expected to be completed soon pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company… Source link
Read More »Moderna Climbs as S&P 500 Set to Welcome Covid Vaccine Maker
(Bloomberg) — Moderna Inc. climbed more than 6% in extended trading Thursday after the vaccine maker was named to the S&P 500 Index in one of the most noteworthy additions to the index since Tesla Inc. joined late last year. The company, whose messenger-RNA vaccine has helped to fight the Covid-19 pandemic, will replace Alexion Pharmaceuticals Inc. in the benchmark U.S. index before the opening of trading on July 21. Alexion is set to be acquired by U.K. drugmaker AstraZeneca Plc. Shares of… Source link
Read More »A man who boosted his Pfizer COVID-19 vaccine with a shot from Moderna said his side effects were a ‘little more severe’ the third time round
From left: Study volunteer and virologist Joseph Hyser, Chanei Henry, senior research coordinator of molecular virology and microbiology, and Dr. Robert Atmar, the principal investigator on the study. Baylor College of Medicine Scientists in the US are starting a booster shot trial, giving fully vaccinated people another jab. Participants are given a booster shot of the Moderna vaccine – whether they previously got 2 shots of an mRNA vaccine (from Pfizer or Moderna) or 1 adenovirus (J&J)… Source link
Read More »CDC: Heart inflammation in young men higher than expected after Pfizer, Moderna vaccines – Yahoo News
Yahoo Entertainment Helen Hunt wanted to direct a ‘Twister’ sequel ‘with all black and brown storm chasers’ but got denied On Watch What Happens Live Thursday, when a conversation with Actress Helen Hunt turned to sequels, host Andy Cohen mentioned the often discussed possibility of a Twister sequel. And wouldn’t you know it? Hunt actually had a pretty interesting idea for one, and it included her directing and co-writing alongside Daveed Diggs and Rafael Casal. “I tried to get it… Source link
Read More »Moderna Scientists And Execs Warn That New Viral Variants Of Covid-19 Coming
New viral variants of the Covid-19 coronavirus are on the way, claimed Moderna scientists and executives in a Thursday virtual investor event, as reported by Barrons. “As the virus spreads, it is rapidly mutating,” the company’s chief scientific officer, Melissa Moore, said on the call. “Some of these new viral strains appear to be even more transmissible than the original strain… We already know that some of these new strains are less susceptible to neutralization by our current… Source link
Read More »